Jaypirca received traditional approval for relapsed/refractory CLL/SLL, showing improved progression-free survival compared to investigator's choice therapy. Breyanzi was approved for ...

On July 10, Westwood Country Club hosted their first-ever Kicks for Kelly Swim-A-Thon, honoring their fellow teammate’s battle against osteosarcoma. Osteosarcoma is a type of bone cancer that most ...

This collaboration aims to enhance supply chain resilience, improve operational efficiency and accelerate readiness for the rapidly expanding global peptides market. This partnership strengthens LMS ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Haley Perry Haley Perry is a staff writer focused on video games and booze.

Alert FDA OKs SMA Gene Therapy Itvisma Itvisma contains the active ingredient in Zolgensma approved in 2019 for children younger than 2 years but is reformulated for intrathecal administration across ...

Shire Pharmaceuticals has announced it will wind down sales of its erythropoietin Dynepo at the end of 2008. Just three years ago, Dynepo had been the cornerstone of Shire's $1.57 billion acquisition ...